Application of enzyme-linked immunosorbent assay to the serological diagnosis of nasopharyngeal carcinoma

LIANG Ying-jie,ZONG Yong-sheng,GU Yao-liang,ZHANG Yu,FENG Yan-fen,LIU Yong-dong,CHEN Yao-long

DOI: https://doi.org/10.3969/j.issn.1006-5725.2008.17.063

2008-01-01

Abstract:Objective Detection of serum levels of the antibodies against EBV by enzyme-linked immunosorbent assay (ELISA) has newly developed for the serological diagnosis of nasopharyngeal carcinoma (NPC). This study is to investigate 4 common antibodies against EBV and the values of dual combination of ELISA in the diagnosis of NPC and to expect to further improve the serological diagnosis of NPC. Methods Serum samples were collected from 195 patients with pathologically diagnosed NPC and from 188 healthy adults in Guangzhou area. Levels of anti-EBV antibodies in the sera were detected by 4 ELISAs based on EBV specific recombinant antigens (glutathione transferase fusion proteins),namely,EBNA1-IgA,EBNA1-IgG,Zta-IgA,and Zta-IgG. Results Among the 4 ELISAs used separately,the sensitivity and specificity of EBNA1-IgA were the highest (0.851 3 and 0.851 1,respectively). The sensitivity and specificity of Zta-IgG were 0.835 9 and 0.835 1,respectively; those of Zta-IgA were 0.810 3 and 0.818 5. The sensitivity and specificity of EBNA1-IgG were the lowest (0.697 4 and 0.696 8,respectively). The specificity and positive predictive value of any dual combination of ELISA could reach more than 0.925 5 and 0.903 2. The odds ratio and positive likelihood ratio of EBNA1-IgA combined with Zta-IgA were the highest (50.626 3 and 14.987 5,respectively),followed by those of EBNA1-IgA plus Zta-IgG (37.090 9 and 11.921 4,respectively). Conclusions Among the 4 types of ELISAs used separately for the serological diagnosis of NPC,EBNA1-IgA is the best,followed by Zta-IgG. Dual combination of ELISA markedly enhances the values of serological diagnosis of NPC. Our study reveals that EBNA1-IgA combined with either Zta-IgA or Zta-IgG is recommendable in the clinical practice.